Literature DB >> 25998421

Effects of dietary nitrate supplementation on the oxygen cost of exercise and walking performance in individuals with type 2 diabetes: a randomized, double-blind, placebo-controlled crossover trial.

Anthony I Shepherd1, Mark Gilchrist2, Paul G Winyard2, Andrew M Jones3, Ewelina Hallmann4, Renata Kazimierczak4, Ewa Rembialkowska4, Nigel Benjamin2, Angela C Shore2, Daryl P Wilkerson5.   

Abstract

Dietary nitrate supplementation has been shown to reduce the oxygen (O2) cost of exercise and enhance exercise tolerance in healthy individuals. This study assessed whether similar effects could be observed in individuals with type 2 diabetes (T2DM). In a randomized, double-blind, placebo-controlled crossover study, 48 participants with T2DM supplemented their diet for 4 days with either nitrate-rich beetroot juice (70ml/day, 6.43mmol nitrate/day) or nitrate-depleted beetroot juice as placebo (70ml/day, 0.07mmol nitrate/day). After each intervention period, resting plasma nitrate and nitrite concentrations were measured subsequent to participants completing moderate-paced walking. Pulmonary gas exchange was measured to assess the O2 cost of walking. After a rest period, participants performed the 6-min walk test (6MWT). Relative to placebo, beetroot juice resulted in a significant increase in plasma nitrate (placebo, 57±66 vs beetroot, 319±110µM; P < 0.001) and plasma nitrite concentration (placebo, 680±256 vs beetroot, 1065±607nM; P < 0.001). There were no differences between placebo juice and beetroot juice for the O2 cost of walking (946±221 vs 939±223ml/min, respectively; P = 0.59) and distance covered in the 6MWT (550±83 vs 554±90m, respectively; P = 0.17). Nitrate supplementation did not affect the O2 cost of moderate-paced walking or improve performance in the 6MWT. These findings indicate that dietary nitrate supplementation does not modulate the response to exercise in individuals with T2DM.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Blood pressure; Exercise; Free radicals; Nitrate; Nitric oxide; Type 2 diabetes

Mesh:

Substances:

Year:  2015        PMID: 25998421     DOI: 10.1016/j.freeradbiomed.2015.05.014

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  20 in total

1.  "Beet" the cold: beetroot juice supplementation improves peripheral blood flow, endothelial function, and anti-inflammatory status in individuals with Raynaud's phenomenon.

Authors:  Anthony I Shepherd; Joseph T Costello; Stephen J Bailey; Nicolette Bishop; Alex J Wadley; Steven Young-Min; Mark Gilchrist; Harry Mayes; Danny White; Paul Gorczynski; Zoe L Saynor; Heather Massey; Clare M Eglin
Journal:  J Appl Physiol (1985)       Date:  2019-07-25

2.  Effect of nitrate supplementation on hepatic blood flow and glucose homeostasis: a double-blind, placebo-controlled, randomized control trial.

Authors:  Anthony I Shepherd; Daryl P Wilkerson; Jon Fulford; Paul G Winyard; Nigel Benjamin; Angela C Shore; Mark Gilchrist
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2016-07-14       Impact factor: 4.052

3.  Dietary nitrate restores compensatory vasodilation and exercise capacity in response to a compromise in oxygen delivery in the noncompensator phenotype.

Authors:  Robert F Bentley; Jeremy J Walsh; Patrick J Drouin; Aleksandra Velickovic; Sarah J Kitner; Alyssa M Fenuta; Michael E Tschakovsky
Journal:  J Appl Physiol (1985)       Date:  2017-06-08

4.  Influence of dietary nitrate supplementation on physiological and muscle metabolic adaptations to sprint interval training.

Authors:  Christopher Thompson; Lee J Wylie; Jamie R Blackwell; Jonathan Fulford; Matthew I Black; James Kelly; Sinead T J McDonagh; James Carter; Stephen J Bailey; Anni Vanhatalo; Andrew M Jones
Journal:  J Appl Physiol (1985)       Date:  2016-12-01

5.  Effect of Acute Dietary Nitrate Supplementation on the Post-Exercise Ambulatory Blood Pressure in Obese Males: A Randomized, Controlled, Crossover Trial.

Authors:  Ágnes D de Lima Bezerra; Eduardo C Costa; Daniela A Pacheco; Daniel C Souza; Luiz F Farias-Junior; Raphael M Ritti-Dia; Gisele B Grigolo; Paulo I H de Bittencourt Júnior; Mauricio Krause; Ana P T Fayh
Journal:  J Sports Sci Med       Date:  2019-02-11       Impact factor: 2.988

6.  Relationship Between Urinary Nitrate Excretion and Blood Pressure in the InChianti Cohort.

Authors:  Miranda J Smallwood; Alessandro Ble; David Melzer; Paul G Winyard; Nigel Benjamin; Angela C Shore; Mark Gilchrist
Journal:  Am J Hypertens       Date:  2017-07-01       Impact factor: 2.689

7.  Effects of Oral Sodium Nitrite on Blood Pressure, Insulin Sensitivity, and Intima-Media Arterial Thickening in Adults With Hypertension and Metabolic Syndrome.

Authors:  Kara S Hughan; Andrea Levine; Nicole Helbling; Steven Anthony; James P DeLany; Maja Stefanovic-Racic; Bret H Goodpaster; Mark T Gladwin
Journal:  Hypertension       Date:  2020-08-03       Impact factor: 10.190

8.  A randomised, factorial trial to reduce arterial stiffness independently of blood pressure: Proof of concept? The VaSera trial testing dietary nitrate and spironolactone.

Authors:  Charlotte E Mills; Virginia Govoni; Luca Faconti; Maria-Linda Casagrande; Steven V Morant; Hannah Crickmore; Fahad Iqbal; Perry Maskell; Alisha Masani; Elisa Nanino; Andrew J Webb; J Kennedy Cruickshank
Journal:  Br J Clin Pharmacol       Date:  2020-02-22       Impact factor: 4.335

9.  Cardiac effects of 6 months' dietary nitrate and spironolactone in patients with hypertension and with/at risk of type 2 diabetes, in the factorial design, double-blind, randomized controlled VaSera trial.

Authors:  Luca Faconti; Charlotte Elizabeth Mills; Virginia Govoni; Haotian Gu; Steven Morant; Benju Jiang; J Kennedy Cruickshank; Andrew James Webb
Journal:  Br J Clin Pharmacol       Date:  2018-11-13       Impact factor: 4.335

10.  Acute interaction between oral glucose (75 g as Lucozade) and inorganic nitrate: Decreased insulin clearance, but lack of blood pressure-lowering.

Authors:  Christopher N Floyd; Satnam Lidder; Joanne Hunt; Sami A Omar; Karen McNeill; Andrew J Webb
Journal:  Br J Clin Pharmacol       Date:  2019-05-09       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.